Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from NATCO Pharma Limited ( (IN:NATCOPHARM) ).
Natco Pharma Limited’s Board of Directors has declared an interim dividend of Rs. 2 per equity share for the financial year 2025-26, with the record date set for August 19, 2025, and payment commencing on August 26, 2025. Additionally, the Board approved an increase in the company’s authorized capital to Rs. 45 crore, subject to shareholder approval, and announced plans for the 42nd Annual General Meeting to be held via video conference.
More about NATCO Pharma Limited
Natco Pharma Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of generic pharmaceuticals. The company is known for its strong presence in the oncology and specialty pharmaceuticals market.
Average Trading Volume: 76,762
Technical Sentiment Signal: Sell
Current Market Cap: 161.2B INR
For a thorough assessment of NATCOPHARM stock, go to TipRanks’ Stock Analysis page.